An Update On Retatrutide May 2025 .

The overall pooled evaluation showed a statistically considerable percent reduction in body weight of the retatrutide group when contrasted to the placebo group after 36 weeks of therapy, with a general MD of − 14.33 (95% CI: − 18.27 to − 10.39, P retatrutide side effects hair loss</a> in obese patients with or without diabetic issues. Early tests of retatrutide exposed that users could lose up to a quarter of their body weight in under a year, making it almost two times as efficient as Ozempic.